Rhonda A. Wallen

Ms. Wallen has 25 years of experience working within the life sciences and healthcare industries. With a focus on business management and corporate development, Ms. Wallen brings board oversight as well as investment expertise. Currently VP Marketing & Corporate Development of SteriLumen, the medical division of AppliedUV, she was most recently the Head of Corporate Development for Terumo BCT, the biomedical division of Terumo Corporation. Previously, Ms. Wallen served as the Chief Operating Officer of Andarix Pharmaceuticals. Also, during this time as a consultant with Cygnet Venture Management, she held senior-level business development and marketing positions where she worked with life science CEOs and founders to validate the strategic direction of emerging growth companies, define key milestones, and complete corporate financings. Ms. Wallen is a Director of Boulder Community Health, and a Board Advisor to venture-backed companies, DrugViu and Aromyx.